JP2020509763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020509763A5 JP2020509763A5 JP2019549562A JP2019549562A JP2020509763A5 JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5 JP 2019549562 A JP2019549562 A JP 2019549562A JP 2019549562 A JP2019549562 A JP 2019549562A JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid construct
- host cell
- nucleotide sequence
- exogenous nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 35
- 102000039446 nucleic acids Human genes 0.000 claims 35
- 150000007523 nucleic acids Chemical class 0.000 claims 35
- 210000004027 cell Anatomy 0.000 claims 25
- 239000002773 nucleotide Substances 0.000 claims 18
- 125000003729 nucleotide group Chemical group 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims 8
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 230000002950 deficient Effects 0.000 claims 6
- 210000000349 chromosome Anatomy 0.000 claims 5
- 239000002609 medium Substances 0.000 claims 5
- 101150116046 PCBD1 gene Proteins 0.000 claims 4
- 101150036331 pah gene Proteins 0.000 claims 4
- 239000006143 cell culture medium Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 claims 2
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 claims 2
- 102100029333 Pterin-4-alpha-carbinolamine dehydratase Human genes 0.000 claims 2
- 150000001413 amino acids Chemical group 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 108010016842 pterin-4a-carbinolamine dehydratase Proteins 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 238000005215 recombination Methods 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762472225P | 2017-03-16 | 2017-03-16 | |
| US62/472,225 | 2017-03-16 | ||
| US201862628018P | 2018-02-08 | 2018-02-08 | |
| US62/628,018 | 2018-02-08 | ||
| PCT/IB2018/051572 WO2018167621A1 (en) | 2017-03-16 | 2018-03-09 | Tyrosine prototrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020509763A JP2020509763A (ja) | 2020-04-02 |
| JP2020509763A5 true JP2020509763A5 (enExample) | 2021-04-08 |
| JP7177076B2 JP7177076B2 (ja) | 2022-11-22 |
Family
ID=61802237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019549562A Active JP7177076B2 (ja) | 2017-03-16 | 2018-03-09 | チロシン原栄養性 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200056190A1 (enExample) |
| EP (1) | EP3596206A1 (enExample) |
| JP (1) | JP7177076B2 (enExample) |
| CA (1) | CA3056182A1 (enExample) |
| WO (1) | WO2018167621A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10738334B2 (en) * | 2015-09-23 | 2020-08-11 | Pfizer Inc. | Cells having reduced BCAT1 |
| US11939601B2 (en) | 2017-11-22 | 2024-03-26 | Modernatx, Inc. | Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria |
| BR112020015798A2 (pt) | 2018-02-01 | 2021-03-09 | Homology Medicines, Inc. | Composições de vírus adeno-associado para restaurar função de gene da pah e métodos de uso das mesmas |
| CA3133330A1 (en) | 2019-03-13 | 2020-09-17 | Generation Bio Co. | Non-viral dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) therapeutics |
| KR20220097910A (ko) * | 2019-11-14 | 2022-07-08 | 론자 리미티드 | 세포 선택 방법 |
| TW202208632A (zh) | 2020-05-27 | 2022-03-01 | 美商同源醫藥公司 | 用於恢復pah基因功能的腺相關病毒組成物及其使用方法 |
| US20230235298A1 (en) * | 2020-06-01 | 2023-07-27 | Modernatx, Inc. | Phenylalanine hydroxylase variants and uses thereof |
| EP4301861A1 (en) | 2021-03-03 | 2024-01-10 | Shape Therapeutics Inc. | Auxotrophic cells for virus production and compositions and methods of making |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4713339A (en) * | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| AU2353384A (en) * | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| US5422120A (en) | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| EP0454781B1 (en) | 1989-01-23 | 1998-12-16 | Chiron Corporation | Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof |
| DE69034168T3 (de) | 1989-03-21 | 2013-04-11 | Vical, Inc. | Expression von exogenen Polynukleotidsequenzen in Wirbeltieren |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6291159B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| EP1645635A3 (en) | 1989-08-18 | 2010-07-07 | Oxford Biomedica (UK) Limited | Replication defective recombinant retroviruses expressing a palliative |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| CA2067194C (en) | 1989-10-05 | 2003-03-18 | Glenn Kawasaki | Cell-free synthesis and isolation of novel genes and polypeptides |
| US6657103B1 (en) | 1990-01-12 | 2003-12-02 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| NZ237464A (en) | 1990-03-21 | 1995-02-24 | Depotech Corp | Liposomes with at least two separate chambers encapsulating two separate biologically active substances |
| GB9021679D0 (en) | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| WO1993010218A1 (en) | 1991-11-14 | 1993-05-27 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Vectors including foreign genes and negative selective markers |
| GB9125623D0 (en) | 1991-12-02 | 1992-01-29 | Dynal As | Cell modification |
| FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
| JPH07507689A (ja) | 1992-06-08 | 1995-08-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 特定組織のターゲティング方法及び組成物 |
| JPH09507741A (ja) | 1992-06-10 | 1997-08-12 | アメリカ合衆国 | ヒト血清による不活性化に耐性のあるベクター粒子 |
| GB2269175A (en) | 1992-07-31 | 1994-02-02 | Imperial College | Retroviral vectors |
| CA2592997A1 (en) | 1992-12-03 | 1994-06-09 | Genzyme Corporation | Pseudo-adenovirus vectors |
| AU6818094A (en) | 1993-04-22 | 1994-11-08 | Depotech Corporation | Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
| JP3532566B2 (ja) | 1993-06-24 | 2004-05-31 | エル. グラハム,フランク | 遺伝子治療のためのアデノウイルスベクター |
| EP0694070B1 (en) | 1993-09-15 | 2002-04-10 | Chiron Corporation | Recombinant alphavirus vectors |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| JP3875990B2 (ja) | 1993-10-25 | 2007-01-31 | カンジ,インコーポレイテッド | 組換えアデノウイルスベクターおよび使用方法 |
| NZ276305A (en) | 1993-11-16 | 1997-10-24 | Depotech Corp | Controlled release vesicle compositions |
| WO1995030763A2 (en) | 1994-05-09 | 1995-11-16 | Chiron Viagene, Inc. | Retroviral vectors having a reduced recombination rate |
| WO1996017072A2 (en) | 1994-11-30 | 1996-06-06 | Chiron Viagene, Inc. | Recombinant alphavirus vectors |
| AU2998597A (en) | 1996-05-06 | 1997-11-26 | Chiron Corporation | Crossless retroviral vectors |
| WO2001068822A2 (en) * | 2000-03-14 | 2001-09-20 | Nilab Aps | Method of treating phenylketonuria and means therefor |
| TWI438010B (zh) | 2002-05-02 | 2014-05-21 | Wyeth Corp | 卡奇黴素(calicheamicin)衍生物-載體共軛物 |
| US9243253B2 (en) * | 2009-05-11 | 2016-01-26 | Pfenex, Inc. | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein |
| WO2012027533A1 (en) | 2010-08-25 | 2012-03-01 | Gt Life Sciences, Inc. | Selectable markers and related methods |
| WO2012145682A1 (en) | 2011-04-21 | 2012-10-26 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
| DK3489366T3 (da) * | 2011-06-01 | 2020-02-24 | Prec Biosciences Inc | Fremgangsmåder og produkter til produktion af manipulerede mammale cellelinier med forstærkede transgener |
| EP2711428A1 (en) | 2012-09-21 | 2014-03-26 | Lonza Biologics plc. | Site-specific integration |
| WO2015032911A1 (en) * | 2013-09-05 | 2015-03-12 | Danmarks Tekniske Universitet | Microorganisms for efficient production of melatonin and related compounds |
| BR112016028564A2 (pt) * | 2014-06-06 | 2018-01-30 | Regeneron Pharma | método para modificar um locus-alvo em uma célula. |
| US10738334B2 (en) * | 2015-09-23 | 2020-08-11 | Pfizer Inc. | Cells having reduced BCAT1 |
-
2018
- 2018-03-09 CA CA3056182A patent/CA3056182A1/en active Pending
- 2018-03-09 US US16/492,793 patent/US20200056190A1/en not_active Abandoned
- 2018-03-09 WO PCT/IB2018/051572 patent/WO2018167621A1/en not_active Ceased
- 2018-03-09 JP JP2019549562A patent/JP7177076B2/ja active Active
- 2018-03-09 EP EP18714080.1A patent/EP3596206A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020509763A5 (enExample) | ||
| CN107435051B (zh) | 一种通过CRISPR/Cas9系统快速获得大片段缺失的细胞系基因敲除方法 | |
| JP7103603B2 (ja) | Ch3ドメインに基づくヘテロダイマー分子、その調製方法及び用途 | |
| JP2018518957A5 (enExample) | ||
| JP2014012014A (ja) | 宿主細胞中の組換えタンパク質の発現を増進するための組換え発現ベクター要素(rEVE) | |
| JP2011504721A5 (enExample) | ||
| CN102703424B (zh) | 一种重组工程介导的大肠杆菌基因组点突变的方法 | |
| CN108424907A (zh) | 一种高通量dna多位点精确碱基突变方法 | |
| RU2007124369A (ru) | Производство белков | |
| EP3159411B1 (en) | Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof | |
| US9752159B2 (en) | Stable expression system for eukaryotic cells | |
| RU2013123638A (ru) | Рекомбинантная плазмидная днк, кодирующая химерное антитело против фактора некроза опухоли-альфа человека, линия эукариотических клеток - продуцент химерного антитела и способ получения химерного антитела | |
| US11136598B2 (en) | Method for cell line development | |
| CN103060367A (zh) | 一种离体高效构建多拷贝乳酸克鲁维酵母表达载体的方法 | |
| CN114774421A (zh) | 运动发酵单胞菌内源性启动子突变体 | |
| CN115595329A (zh) | 一种用于蛋白质合成的表达序列的构建方法 | |
| WO2025141778A1 (ja) | 新規プロモーター | |
| CN104404069A (zh) | 一种低拷贝pTerm质粒及其构建方法和应用 | |
| CN104120119B (zh) | 一种3-脱氢奎尼酸合成酶突变体及其基因和应用 | |
| WO2025177984A1 (ja) | 二本鎖環状dnaベクター | |
| CN1657628A (zh) | 一种高效筛选目的蛋白的表达载体,其制备方法及用途 | |
| CN117683804A (zh) | 一种核酸构建物以及在ivtt体系中的应用 | |
| CN109153985A (zh) | 转化体、以及转铁蛋白的制造方法 | |
| CN116555261A (zh) | 一种乳酸片球菌启动子文库及其构建方法和应用 | |
| KR102010246B1 (ko) | 미세조류 에틀리아 유래의 프로모터 및 이의 용도 |